Clinical trials recruiting for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Acoramidis (356 mg film-coated tablets) | 1 |
| NNC6019-0001 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 1 |
| California | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Georgia | 1 |
| Hawaii | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Louisiana | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
Top cities
Self-screener
Recruiting trials
- A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Thailand ATTR-CM Registry
Related conditions
Trials recruiting for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.